SA Transcripts • Fri, Nov. 14
Be smarter and faster with PRO Alerts on EMIS
Fri, Nov. 14, 12:13 PM| Comment!
Fri, Nov. 14, 8:36 AM
Wed, Nov. 12, 9:34 AM
Wed, Aug. 20, 11:00 AM
- Emisphere (OTCQB:EMIS +24%) sets up a $20M loan facility with MHR Fund Management (and certain MHR affiliates) to fund the U.S. commercialization of Eligen B12. The facility will mature on December 31, 2019 and bear interest of 13% per year.
- The company and MHR also consummate an agreement that obligates Emisphere to pay MHR royalties on the sale and licensing of Eligen B12 and related products.
Thu, Aug. 14, 3:51 PM
Nov. 12, 2013, 8:27 AM
EMIS vs. ETF Alternatives
Other News & PR